New Questions Emerge As Gabbard's Biolab Disclosure Collides With Senate Covid Report




A fresh political storm is brewing in Washington after Director of National Intelligence Tulsi Gabbard disclosed the existence of more than 120 US-funded biological laboratories operating across more than 30 countries, including facilities involved in research on dangerous pathogens and, in some cases, gain-of-function experiments.


By elocal International Desk

The disclosure comes as a separate report prepared for the Senate Homeland Security and Governmental Affairs Committee (SHSGAC) gains renewed attention online, with the document advancing a controversial theory linking the DEFUSE proposal, EcoHealth Alliance research, coronavirus engineering programs and the global Covid-19 pandemic.

Taken together, the two developments are reigniting questions that many believed had been settled years ago.

Gabbard: The Public Was Not Told The Full Story

In a video statement released this week, Gabbard said intelligence reviews had uncovered evidence of longstanding US government funding for biological laboratories around the world.

According to Gabbard:

"Today I'm releasing new evidence of longstanding US government funding of more than 120 biolabs in over 30 countries."

She further stated that some of these facilities handled dangerous pathogens and that certain laboratories had engaged in gain-of-function research with what she described as limited oversight and transparency.

Perhaps most significantly, Gabbard alleged that information about the scope and funding of these facilities had been deliberately withheld from the American public.

"Until now, evidence regarding the full existence and funding of these laboratories had been knowingly withheld from you, the American people."

The comments represent one of the strongest public statements yet from a senior US intelligence official regarding overseas biological research programs.

A Senate Report Raises Further Questions

At almost the same time, excerpts from a report prepared for the Senate Homeland Security and Governmental Affairs Committee began circulating widely online.

The report examines the DEFUSE proposal — a controversial 2018 research project involving EcoHealth Alliance and coronavirus research programs that was ultimately not funded by DARPA.

The report advances a detailed hypothesis that Covid-19 may be connected to broader coronavirus engineering and vaccine-development research activities that predated the pandemic.

Among its key claims are assertions that:

  • The nature of SARS-CoV-2 may be consistent with research connected to coronavirus vaccine development.
  • The virus may have characteristics associated with engineered spike-protein research.
  • Public health responses may have misunderstood aspects of the pathogen's behaviour.
  • Vaccine design strategies may warrant further examination.
  • Gain-of-function research deserves much greater scrutiny.

The report does not represent an official US government conclusion on Covid origins. However, its significance lies in the fact that such questions are now appearing within material prepared for a Senate committee rather than solely among independent researchers and alternative media outlets.

A Debate Once Dismissed Is Now Mainstream

The most striking aspect of recent developments is how dramatically the public conversation has changed.

In 2020 and 2021, suggestions that laboratory research may have played a role in the pandemic were frequently dismissed as misinformation or conspiracy theories.

Today, the situation is very different.

Questions surrounding:

  • The Wuhan Institute of Virology
  • EcoHealth Alliance
  • Gain-of-function research
  • The DEFUSE proposal
  • Intelligence agency assessments
  • Laboratory safety protocols

are now openly discussed by journalists, policymakers, intelligence officials and scientific researchers.

Gabbard's comments suggest that scrutiny is expanding beyond China and increasingly focusing on the global network of laboratories funded by Western governments and agencies.

Why The Two Stories Matter Together

Neither Gabbard's disclosure nor the SHSGAC report proves how Covid-19 began.

What they do reveal is that the debate is moving into a new phase.

Gabbard's statement focuses on the existence, funding and oversight of international biological laboratories.

The Senate report attempts to explore what some of that research may have involved and whether it could help explain aspects of the pandemic that remain unresolved.

Viewed together, they point toward a larger question:

How much biological research involving dangerous pathogens was taking place around the world before 2020, who funded it, and how much did governments know?

Those questions are no longer being asked solely by independent investigators.

They are now being raised from within the highest levels of the United States intelligence and political establishment itself.

The Bigger Issue

For many observers, the central issue is no longer whether biological laboratories exist or whether gain-of-function research occurred.

Both are now widely acknowledged.

The emerging debate is about transparency, accountability and oversight.

If government-funded research involving potentially pandemic-capable pathogens was taking place across a global network of laboratories, many will ask why the public was not informed sooner and whether existing safeguards were adequate.

As more documents are released and more investigations proceed, the political and scientific consequences could be significant.

One thing is becoming increasingly clear: the story of Covid-19 is not finished.


The SHSGAC Report

Page 9

UNCLASSIFIED

Image Text

inserted into a recombinant bat SARSr-CoV backbone. It is likely a live vaccine not yet engineered to a more attenuated state that the program sought to create with its final version. It leaked and spread rapidly because it was aerosolized so it could efficiently infect bats in caves, but it was not ready to infect bats yet, which is why it does not appear to infect bats. The reason the disease is so confusing is because it is less a virus than it is engineered spike proteins hitch-hiking a ride on a SARSr-CoV quasispecies swarm. The closer it is to the final live attenuated vaccine form, the more likely that it has been deattenuating since initial escape in August 2019.

The utility of certain countermeasures can be extrapolated from the documents:

• The team selected for SARSr-CoVs that were most monoclonal antibody and vaccine resistant.

• It is not practical to inoculate bats directly with shots, nor can bats get respiratory infections from droplets, so the team developed an aerosol to deliver the inoculations directly into the caves. To ensure it worked well, they developed the aerosol against masked civets.

• The proposal notes that interferon, Remdesivir, and chloroquine phosphate inhibit SARSr-CoV viral replication.

Because of its (now) known nature, the SARSr-CoV-WIV's illness is readily resolved with early treatment that inhibits the viral replication that spreads the spike proteins around the body (which induce a harmful overactive immune response as the body tries to clear the spikes from the ACE2 receptors). Many of the early treatment protocols ignored by the authorities work because they inhibit viral replication or modulate the immune response to the spike proteins, which makes sense within the context of what EcoHealth was creating. Some of these treatment protocols also inhibit the action of the engineered spike protein. For instance, Ivermectin (identified as curative in April 2020) works throughout all phases of illness because it both inhibits viral replication and modulates the immune response. Of note, chloroquine phosphate (Hydroxychloroquine, identified April 2020 as curative) is identified in the proposal as a SARSr-CoV inhibitor, as is interferon (identified May 2020 as curative).

The gene-encoded, or “mRNA,” vaccines work poorly because they are synthetic replications of the already-synthetic SARSr-CoV-WIV spike proteins and possess no other epitopes. The mRNA instructs the cells to produce synthetic copies of the SARSr-CoV-WIV synthetic spike protein directly into the bloodstream, wherein they spread and produce the same ACE2 immune storm that the recombinant vaccine does. Many doctors in the country have identified that the symptoms of vaccine reactions mirror the symptoms of the disease, which corroborates with the similar synthetic nature and function of the respective spike proteins. The vaccine recipient has no defense against the bloodstream entry, but their nose protects them from the recombinant spike protein quasispecies during “natural infection” (better termed as aerosolized inoculation).

UNCLASSIFIED

For SHSGAC Use Only - SHSGAC_COVID_119th 011834


Page 10

UNCLASSIFIED

Image Text

Furthermore, the EcoHealth proposal states that a “vaccine approach lacks sufficient epitope coverage to protect against quasispecies of coronavirus.” Consequently, they were trying to make vaccines work by “targeted immune boosting via vaccine inoculators using chimeric polyvalent recombinant spike proteins.” The nature of using a spike protein vaccine with one epitope against a spike protein vaccine with a quasispecies may explain the unusual (and potentially detrimental) antibody response amongst the vaccinated to the new COVID variants. Fundamentally, the knowledge the proposal provides signals that the risk of Antibody Dependent Enhancement (ADE) from vaccination should be evaluated with high priority, on top of the reality that single-epitope vaccines will have little effect against SARSr-CoV-WIV, as indicated in the proposal.

The potential for SARSr-CoV-WIV to deattenuate requires immediate attention. Live vaccines have been found to deattenuate in the past. If this is the case with SARSr-CoV-WIV, then the mass vaccination campaign actually performs an accelerated gain-of-function for it. Since it is designed for bats off of a human-susceptible SARS-CoV, vaccinating humans against it actually gains its function back towards a more deattenuated human-susceptible form. Improving the SARSr-CoV-WIV spike protein to gain robustness against monoclonal vaccines is one of the steps of the DEFUSE program. The mechanism to improve the SARSr-CoV-WIV spike protein (other than direct engineering) is to challenge it against animals that have spike protein-only antibodies. The attenuated virus will either die or adapt its form to neutralize the spike protein-only antibodies. The intent was to perform this task against humanized mice and then “batified” mice. Instead, it was done with the world's population.

SARSr-CoV-WIV is not meant to kill the bats, but to immunize them. This nature may explain its general harmlessness to most people, and its harmfulness to the old and comorbid, who are in general more susceptible to vaccine reactions. The asymptomatic nature is also explained by the bat vaccine-intention of its creators (a good vaccine does not generate symptoms). Such effects would be expected of an immature vaccine, or a vaccine being reverse engineered from a more virulent form into an attenuated form. The spike protein effect on ACE2 receptors exacerbates the harmfulness in accordance with age and comorbidity. The nature of SARSr-CoV-WIV's deattenuation will also indicate future virulence, though knowing its nature at last neutralizes the threat as effective treatments can be applied with confidence.

3. DRASTIC and other scientists will clean up my description of SARSr-CoV-WIV's nature and progression within the DEFUSE program. This information is sufficient for an investigative report and more than enough to correct the existing pandemic strategy. Previously, the nation did not know itself, nor the adversary in the pandemic conflict. Now it knows both. The problem can be framed appropriately and specifically against a confirmed hypothesis. Limiting disease transmission can be dropped as the implied strategic end, as it is not the actual problem,

UNCLASSIFIED

For SHSGAC Use Only - SHSGAC_COVID_119th 011835


Primary Source: Remarks by Director of National Intelligence Tulsi Gabbard, June 2026

Supporting Source: SHSGAC Covid report excerpts relating to DEFUSE, EcoHealth Alliance and coronavirus research

This report examines claims, statements and documents currently generating public debate. The origins of Covid-19 remain the subject of ongoing investigation and scientific discussion.

Advertisement

read more…

When Pāpāmoa Comes Together

One Night. Thousands Helped.

JOBS DISAPPEAR, PRICES RISE: WHO IS PAYING THE PRICE?

The Household Squeeze

The Coastguard Hero Bringing Kiwis Home

Westfield Albany's 2026 Local Hero Rachel Hessey

GREENLAND: A New Model of Global Power?

Sovereignty Without Annexation

BITCOIN CRASH: The Illusion of Financial Independence?

Crypto Meets Market Reality

share article

or copy this link: